About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Atorvastatin Calcium Trihydrate
- Company
- Daiichi Sankyo
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 37 recruiting
Efficacy results: Not yet reported
37 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Sep 19, 2026
Find a Clinical Trial Near Me
See recruiting studies for Atorvastatin Calcium Trihydrate and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT04262206
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Not yet reported Duke University 20000 participants Est. completion 2026-12-31 106 sites Stand-aloneCardiovascular disease Other conditions: Cognitive Impairment, Mild, DementiaView official trial listing → -
Recruiting NCT NCT04347434
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
Not yet reported Penza State University 300 participants Est. completion 2027-12-30 1 site Stand-aloneCardiovascular disease Other conditions: Myocardial Strain, Arterial Stiffness, Quality of LifeView official trial listing → -
Recruiting NCT NCT04847752
Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
Tongji Hospital 1000 participants Est. completion 2028-12-31 1 siteCardiovascular disease Other conditions: Large-Artery Atherosclerosis (Embolus/Thrombosis)View official trial listing → -
Recruiting NCT NCT05028829
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Not yet reported Raymond Chung 60 participants Est. completion 2031-03-01 2 sites Stand-aloneOther conditions: Liver Fibroses, CirrhosisView official trial listing → -
Recruiting NCT NCT05289063
Vascular Endothelial Dysfunction in Sleep Apnea
Not yet reported Columbia University 110 participants Est. completion 2027-02-28 1 siteObstructive sleep apneaView official trial listing → -
Recruiting NCT NCT05483010
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
Not yet reported Washington University School of Medicine 16 participants Est. completion 2028-05-31 1 site Stand-aloneOther conditions: Clonal Cytopenia of Undetermined Significance, Myelodysplastic SyndromesView official trial listing → -
Recruiting NCT NCT05705804
Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
Not yet reported Yonsei University 250 participants Est. completion 2027-06-01 1 siteCardiovascular disease Other conditions: DyslipidemiasView official trial listing → -
Recruiting NCT NCT05796973
Measuring Oncological Value of Exercise and Statin
Not yet reported Tampere University Hospital 240 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Prostate Cancer, Breast Cancer, Kidney Cancer, Ovarian Cancer, Metastatic Breast Cancer, Metastatic Kidney Cancer, Metastatic Renal Cell Carcinoma, Metastatic Renal Cancer, Metastatic Prostate Cancer, Metastatic Prostate Adenocarcinoma, Metastatic Ovarian Cancer, Metastatic Ovary CancerView official trial listing → -
Recruiting NCT NCT06102863
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Not yet reported Peking University People's Hospital 38 participants Est. completion 2025-09-01 1 site Stand-aloneOther conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage IView official trial listing → -
Recruiting NCT NCT06199921
ATORvastatin in Pulmonary TUBerculosis
Not yet reported Obafemi Awolowo University Teaching Hospital 440 participants Est. completion 2026-09-30 8 sites Stand-aloneOther conditions: Pulmonary Tuberculosis, Tuberculosis, Koch's DiseaseView official trial listing → -
Recruiting NCT NCT06308952
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
Not yet reported Duan Chuanzhi 354 participants Est. completion 2027-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Cerebrovascular Event, Stent Stenosis, Stent Thrombosis, Death, Brain, Endothelial DysfunctionView official trial listing → -
Recruiting NCT NCT06312748
Novel Approaches for Improving Vascular Function in Veterans With HFpEF
Not yet reported VA Office of Research and Development 90 participants Est. completion 2030-09-30 1 site Stand-aloneHeart failure Other conditions: InflammationView official trial listing → -
Recruiting NCT NCT06327451
Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma
Not yet reported Tianjin Medical University General Hospital 50 participants Est. completion 2027-02-28 1 site Stand-aloneOther conditions: Glioblastoma, IDH-wildtypeView official trial listing → -
Recruiting NCT NCT06336174
Cognitive Decline and Underlying Mechanisms in Symptomatic Intracranial Artery Stenosis Patients: A Cohort Study
Anhui Medical University 100 participants Est. completion 2026-12-31 1 siteOther conditions: Intracranial Atherosclerosis, Cognitive Impairment, Cerebrovascular EventView official trial listing → -
Recruiting NCT NCT06358313
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Small Vessel Stroke
Not yet reported Kafrelsheikh University 600 participants Est. completion 2026-05-30 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06485336
Prophylactic Treatment With Atorvastatin for Chronic Migraine (ChronicStatinMig)
Not yet reported St. Olavs Hospital 300 participants Est. completion 2029-02-28 6 sitesOther conditions: Chronic MigraineView official trial listing → -
Recruiting NCT NCT06501443
LATAM LOWERS LDL-C
Not yet reported Novartis Pharmaceuticals 520 participants Est. completion 2026-11-29 11 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Recruiting NCT NCT06604117
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
Xuanwu Hospital, Beijing 200 participants Est. completion 2027-10 1 siteCardiovascular disease Other conditions: Atherosclerosis of Artery, Lipid Disorder, StatinView official trial listing → -
Recruiting NCT NCT06686615
A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 2000 participants Est. completion 2028-01-31 163 sitesOther conditions: Primary Hypercholesterolemiia, Mixed DyslipidemiaView official trial listing → -
Recruiting NCT NCT06690164
Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone
Not yet reported National University Hospital, Singapore 78 participants Est. completion 2026-06 1 site Stand-aloneOther conditions: MetaboliteView official trial listing → -
Recruiting NCT NCT06750783
The Effects of Xuezhikang and Atorvastatin on Lipid in Patients With Dyslipidemia and Prediabetes
Not yet reported Beijing Tsinghua Chang Gung Hospital 398 participants Est. completion 2026-03-31 3 sites Stand-aloneOther conditions: Prediabetic State (IGT)View official trial listing → -
Recruiting NCT NCT06765265
Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome
Not yet reported King Edward Medical University 152 participants Est. completion 2026-01-01 1 siteOther conditions: Acute Coronary SyndromesView official trial listing → -
Recruiting NCT NCT06789432
Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population
Not yet reported Dr. Md. Alimur Reza 500 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: Hyperlipidemia (E.G., Hypercholesterolemia)View official trial listing → -
Recruiting NCT NCT06858332
Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
Novartis Pharmaceuticals 2382 participants Est. completion 2027-09-30 20 sitesCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06896708
Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome
Not yet reported Liu yong 766 participants Est. completion 2028-03-01 7 sites Stand-aloneOther conditions: Chronic Coronary SyndromeView official trial listing → -
Recruiting NCT NCT06922994
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
Not yet reported Centro Cardiologico Monzino 102 participants Est. completion 2026-11-30 5 sitesOther conditions: Arrhythmogenic CardiomyopathyView official trial listing → -
Recruiting NCT NCT06930885
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Not yet reported Hospital do Coracao 7713 participants Est. completion 2031-05 13 sites Stand-aloneCardiovascular disease Other conditions: Atherothrombotic DiseasesView official trial listing → -
Recruiting NCT NCT06975111
Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
Not yet reported, Not yet reported University of Colorado, Denver 200 participants Est. completion 2030-10-01 3 sitesOther conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, CardiovascularView official trial listing → -
Recruiting NCT NCT07045142
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
Not yet reported Central South University 400 participants Est. completion 2028-06-01 8 sitesOther conditions: SchizophreniaView official trial listing → -
Recruiting NCT NCT07083206
A Study to Evaluate the Effectiveness and Safety of Fixed-Dose Combination of Pitavastatin/ Ezetimibe
Ahn-Gook Pharmaceuticals Co.,Ltd 4500 participants Est. completion 2029-01 1 siteOther conditions: Hypercholesterolemia, DyslipidemiasView official trial listing → -
Recruiting NCT NCT07088250
Statins for Treatment of Primary Intracerebral Hemorrhage
Not yet reported The Second Hospital of Anhui Medical University 264 participants Est. completion 2026-12-31 22 sites Stand-aloneOther conditions: Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage, Intracerebral HaemorrhageView official trial listing → -
Recruiting NCT NCT07344610
Effects of Short-term Intensive Statin Therapy on Lipid Levels
General Hospital of Shenyang Military Region 800 participants Est. completion 2026-12-30 1 siteCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT07611747
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Not yet reported Instituto de Investigación Marqués de Valdecilla 1944 participants Est. completion 2031-12 17 sites Stand-aloneOther conditions: Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE), Caridovascular Disease, Atherosclerosis, Carotid Artery DiseasesView official trial listing → -
Recruiting NCT NCT07680595
Prospective Management of Plaque Instability With Statins and Extra Folic Acid
Not yet reported, Not yet reported Ruijin Hospital 180 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Carotid Atherosclerotic PlaqueView official trial listing → -
Recruiting NCT NCT07685938
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Not yet reported UNC Lineberger Comprehensive Cancer Center 60 participants Est. completion 2029-02 1 site Stand-aloneOther conditions: Chest Wall Tumor, Breast Cancer, Lung Cancer, Esophageal Cancer, Mediastinal Cancers, Spine Metastases, Spinal Tumor, Thoracic Cancer, Thoracic NeoplasmsView official trial listing → -
Recruiting NCT NCT07704918
Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Not yet reported University of Colorado, Denver 40 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: MelanomaView official trial listing → -
Recruiting NCT NCT07727681
Perioperative Statins to Prevent AFib After Lung Surgery
Not yet reported Peking Union Medical College Hospital 540 participants Est. completion 2028-01-02 2 sites Stand-aloneOther conditions: Postoperative Atrial Fibrillation, Lung SurgeryView official trial listing → -
Completed NCT NCT00000941
A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 56 participants Est. completion 2002-03 13 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00017758
The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 56 participants 10 sitesOther conditions: HIV Infections, HIV Seronegativity, LipodystrophyView official trial listing → -
Completed NCT NCT00065806
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
Not yet reported Laura Schanberg 221 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Lupus Erythematosus, SystemicView official trial listing → -
Completed NCT NCT00072826
Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease
Not yet reported National Institutes of Health Clinical Center (CC) 44 participants Est. completion 2007-08-24 1 siteOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT00081731
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
Not yet reported Baim Institute for Clinical Research 947 participants Est. completion 2013-09 1 siteCardiovascular disease Other conditions: Atherosclerosis, Hypertension, Renovascular, Renal Artery ObstructionView official trial listing → -
Completed NCT NCT00094172
Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 82 participants Est. completion 2009-05 14 sites Stand-aloneOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00103974
Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis
Not yet reported Bayhill Therapeutics 30 participants Est. completion 2007-03 4 sitesOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00110435
A Multicenter Study to Evaluate the Cholesterol Lowering Effects of Two Marketed Products in Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia (MK-0653A-077)
Not yet reported Organon and Co 1229 participants Est. completion 2005-12Type 2 diabetes Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00115817
The Effects of Atorvastatin in Patients With Atherosclerosis
Not yet reported Brigham and Women's Hospital 36 participants Est. completion 2007-03 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00120133
Atorvastatin (Lipitor) to Prevent Bone Pain
Not yet reported Children's Mercy Hospital Kansas City 12 participants Est. completion 2007-12 1 siteOther conditions: OsteoporosisView official trial listing → -
Completed NCT NCT00126048
Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma
Not yet reported, Not yet reported University of Glasgow 54 participants Est. completion 2007-09 1 siteOther conditions: AsthmaView official trial listing → -
Completed NCT NCT00127218
High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
Not yet reported Johns Hopkins University 145 participants Est. completion 2008-12 1 site Stand-aloneCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00130481
Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
Not yet reported University of Florida 100 participants Est. completion 2007-04 1 siteType 2 diabetes Other conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00132717
A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)
Not yet reported Organon and Co 450 participants Est. completion 2007-06-01Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00134511
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
Not yet reported Pfizer 30 participants Est. completion 2005-11 6 sitesOther conditions: Hypercholesterolemia, FamilialView official trial listing → -
Completed NCT NCT00134550
Improving Diabetic Foot Ulcers With Atorvastatin
Not yet reported Asker & Baerum Hospital 13 participants Est. completion 2007-03 2 sitesOther conditions: Foot Ulcer, DiabetesView official trial listing → -
Completed NCT NCT00136942
A Swiss Study With Atorvastatin in Hyperlipidemic Patients Measuring LDL-Cholesterol
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 370 participants 20 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00137462
Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.
Not yet reported Pfizer 900 participants Est. completion 2006-09 59 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00138762
A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol
Not yet reported Pfizer 3800 participants Est. completion 2006-08 154 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00141141
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 383 participants Est. completion 2007-04 35 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00143741
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
Not yet reported University of Chicago 20 participants Est. completion 2011-07 1 siteOther conditions: End-Stage Kidney DiseaseView official trial listing → -
Completed NCT NCT00150384
Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2005-08 106 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00150722
High-Density Lipoprotein (HDL) Modulation and Endothelial Function
Not yet reported University of Calgary 75 participants Est. completion 2008-08 1 siteOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00151502
To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 600 participants Est. completion 2007-07 99 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT00157924
Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)
Not yet reported Organon and Co 190 participants Est. completion 2007-09Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00159835
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD
Not yet reported Pfizer 8600 participants Est. completion 2005-03 194 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00163150
Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 128 participants Est. completion 2006-02 1 siteOther conditions: Cerebrovascular Accident, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00166036
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
Not yet reported Emory University 36 participants Est. completion 2009-04 1 site Stand-aloneMetabolic syndrome Other conditions: Diabetes Mellitus, HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00181181
The Effect of Statin Use on Vascular Function in Hypertensive Subjects
Not yet reported Johns Hopkins University 24 participants Est. completion 2007-04 1 siteOther conditions: HypertensionView official trial listing → -
Status unknown NCT NCT00201552
Statin and PAF in Patients With Pacemaker
Not yet reported National Taiwan University Hospital 1 siteOther conditions: Paroxysmal Atrial FibrillationView official trial listing → -
Completed NCT NCT00202904
Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)
Not yet reported Organon and Co 81 participants Est. completion 2006-10 Stand-aloneOther conditions: Hypercholesterolemia, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00211939
CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
Not yet reported Nabi Biopharmaceuticals 203 participants Est. completion 2007-03 1 site Stand-aloneOther conditions: Calcinosis, Arteriosclerosis, Hyperparathyroidism, SecondaryView official trial listing → -
Completed NCT NCT00214630
LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
Not yet reported AstraZeneca 825 participants Est. completion 2007-08 56 sitesOther conditions: Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT00233480
Statin Therapy in Heart Failure: Potential Mechanisms of Benefit
Not yet reported University of California, Los Angeles 27 participants Est. completion 2009-02 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT00241488
DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia
Not yet reported AstraZeneca 1362 participants Est. completion 2007-02 34 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00242944
Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)
Not yet reported Kyoto University 307 participants Est. completion 2008-03 3 sitesOther conditions: Coronary Disease, HypercholesterolemiaView official trial listing → -
Withdrawn NCT NCT00243672
Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques
Not yet reported University Hospital Muenster 100 participants Est. completion 2007-10Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00249249
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
Not yet reported Kowa Research Europe 830 participants Est. completion 2006-11 192 sitesOther conditions: Primary Hypercholesterolemia, DyslipidemiaView official trial listing → -
Completed NCT NCT00251680
Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.
Not yet reported Takeda 400 participants Est. completion 2007-05 77 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT00252967
Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
Not yet reported Emory University 64 participants Est. completion 2009-10 3 sites Stand-aloneOther conditions: Atrial Fibrillation, InflammationView official trial listing → -
Completed NCT NCT00259662
High-dose Periop Statins for Prevention of DVT
Not yet reported Yale University 29 participants Est. completion 2007-08 1 siteOther conditions: Gynecologic Oncological Pelvic/Abdominal SurgeryView official trial listing → -
Terminated NCT NCT00267267
A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder.
Not yet reported Pfizer 1784 participants Est. completion 2007-01 123 sitesOther conditions: Hyperlipidemia, DyslipidemiaView official trial listing → -
Completed NCT NCT00276458
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
Not yet reported Organon and Co 196 participants Est. completion 2008-01 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00286312
Myocardial Infarction Size Reduction With Atorvastatin
Not yet reported R&D Cardiologie 50 participants Est. completion 2008-02 2 sitesCardiovascular disease Other conditions: Reperfusion InjuryView official trial listing → -
Completed NCT NCT00289900
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
Not yet reported Merck Sharp & Dohme LLC 2340 participants Est. completion 2010-08-06Other conditions: Mixed HyperlipidemiaView official trial listing → -
Completed NCT NCT00296387
Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
Not yet reported AstraZeneca 1160 participants Est. completion 2007-10 102 sitesOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT00297973
Cardiovascular Risk Assessment in Patients Treated With Caduet
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1442 participants Est. completion 2007-04 384 sitesOther conditions: HypertensionView official trial listing → -
Completed NCT NCT00299884
Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering Strategy
Queen's University 45 participants Est. completion 2006-07 1 siteOther conditions: Dyslipidemia, Vascular DiseaseView official trial listing → -
Completed NCT NCT00300469
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood
Not yet reported Abbott 613 participants 1 siteOther conditions: Mixed Dyslipidemia, Coronary Heart Disease, DyslipidemiaView official trial listing → -
Completed NCT NCT00309751
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Not yet reported Kowa Research Europe 418 participants Est. completion 2007-06 35 sitesOther conditions: Type II Diabetes Mellitus, DyslipidemiaView official trial listing → -
Completed NCT NCT00319449
Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
Not yet reported Organon and Co 22 participants Est. completion 2006-10 Stand-aloneOther conditions: Hypercholesterolemia, Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT00327691
A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
Not yet reported Pfizer 8600 participants Est. completion 2004-08 314 sitesCardiovascular disease Other conditions: Cerebrovascular Accident, Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00329069
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
Not yet reported University of Ulm 50 participants Est. completion 2006-03 1 siteCardiovascular disease Other conditions: Hypercholesterolemia, Monocyte FunctionView official trial listing → -
Completed NCT NCT00329173
PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin.
Not yet reported AstraZeneca 1000 participants Est. completion 2004-08Other conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00330785
Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1250 participants Est. completion 2005-09 126 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00332761
Caduet in an Untreated Subject Population
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2007-09 34 sitesOther conditions: Hypertension, DyslipidemiaView official trial listing → -
Completed NCT NCT00335699
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
Not yet reported AstraZeneca 370 participants Est. completion 2007-01 7 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00344370
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
Not yet reported Kowa Research Europe 214 participants Est. completion 2008-04 35 sitesOther conditions: Type II Diabetes Mellitus, DyslipidemiaView official trial listing → -
Completed NCT NCT00356473
Effects of Atorvastatin on Disease Activity and HDL Cholesterol Function in Patients With Rheumatoid Arthritis
Not yet reported University of California, Los Angeles 20 participants Est. completion 2005-09 Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00359281
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents
Not yet reported Aegerion Pharmaceuticals, Inc. 125 participants Est. completion 2007-11 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00361283
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
Not yet reported University of Florida 108 participants Est. completion 2009-01 1 siteOther conditions: InflammationView official trial listing → -
Completed NCT NCT00362934
Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin
Not yet reported Solvay Pharmaceuticals 516 participants Est. completion 2008-08 68 sitesOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT00368589
Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
GlaxoSmithKline 47 participants Est. completion 2007-08 1 siteOther conditions: Atherosclerotic Carotid Disease, Atheroma, AtherosclerosisView official trial listing → -
Completed NCT NCT00375518
Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery
Not yet reported Memorial Sloan Kettering Cancer Center 162 participants Est. completion 2014-05 1 siteOther conditions: Thoracic SurgeryView official trial listing → -
Completed NCT NCT00380939
This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.
Not yet reported Pfizer 600 participants Est. completion 2000-12 36 sitesOther conditions: Coronary ArteriosclerosisView official trial listing → -
Completed NCT NCT00388596
A Study Of SB-751689, Atorvastatin, Ketoconazole, And Rosuvastatin In Health Postmenopausal Women.
Not yet reported GlaxoSmithKline 36 participants 1 siteOther conditions: OsteoporosisView official trial listing → -
Terminated NCT NCT00395603
Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)
Not yet reported Organon and Co 550 participants Est. completion 2007-06Cardiovascular disease Other conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00396721
Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
Not yet reported Josep m Cruzado 23 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Glomerulonephritis, IGA, Nephropathy, IGA, IGA NephropathyView official trial listing → -
Completed NCT NCT00405717
Effects of Atorvastatin Versus Pravastatin on Platelet Inhibition by Clopidogrel
Not yet reported Shenyang Northern Hospital 1300 participants Est. completion 2008-05 1 siteOther conditions: Ischemic Heart Disease, Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT00408382
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
Not yet reported Astellas Pharma Inc 50 participants 2 sitesCardiovascular disease Other conditions: HypercholesteremiaView official trial listing → -
Terminated NCT NCT00412841
Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus
Not yet reported NYU Langone Health 43 participants Est. completion 2008-01 1 site Stand-aloneOther conditions: Avascular NecrosisView official trial listing → -
Completed NCT NCT00418834
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
Not yet reported Organon and Co 1053 participants Est. completion 2008-10Other conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00427960
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
Not yet reported AstraZeneca 55 participants Est. completion 2008-02 9 sitesOther conditions: HypercholesterolaemiaView official trial listing → -
Completed NCT NCT00441597
Does Atorvastatin Reduce Ischemia-Reperfusion Injury in Humans in-Vivo?
Not yet reported Radboud University Medical Center 30 participants Est. completion 2009-03 1 siteCardiovascular disease Other conditions: Ischemia Reperfusion InjuryView official trial listing → -
Completed NCT NCT00446940
Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C
Not yet reported Bader, Ted, M.D. 16 participants Est. completion 2007-03 1 siteOther conditions: Hepatitis CView official trial listing → -
Status unknown NCT NCT00452608
Statin for Immunomudulation in Sepsis
Not yet reported Hospital de Clinicas de Porto Alegre 80 participants Est. completion 2009-12 1 siteOther conditions: SepsisView official trial listing → -
Completed NCT NCT00457340
Atorvastatin For The Reduction Of Ventricular Arrhythmias
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 220 participants Est. completion 2004-09 10 sitesOther conditions: ArrhythmiaView official trial listing → -
Completed NCT NCT00457405
Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
Not yet reported Radboud University Medical Center 10 participants Est. completion 2008-03 1 siteOther conditions: Ischemia-Reperfusion Injury, AtherosclerosisView official trial listing → -
Completed NCT NCT00462748
A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)
Not yet reported Organon and Co 786 participants Est. completion 2008-06Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00463827
Effect of Statins on Asthma Control in Smokers With Asthma
Not yet reported NHS Greater Clyde and Glasgow 71 participants Est. completion 2009-06 1 siteOther conditions: Asthma, COPD, SmokingView official trial listing → -
Completed NCT NCT00465088
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)
Not yet reported Abbott 199 participants 46 sites Stand-aloneOther conditions: Hyperlipidemia, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00469326
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
Not yet reported University Hospital, Motol 200 participants Est. completion 2008-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00479388
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
Not yet reported Merck Sharp & Dohme LLC 1216 participants Est. completion 2008-10Other conditions: Primary Hypercholesterolemia, Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT00505336
The Effect of Eplerenone and Atorvastatin on Markers of Collagen Turnover in Diastolic Heart Failure
Not yet reported St Vincent's University Hospital, Ireland 43 participants Est. completion 2008-12 1 site Stand-aloneHeart failureView official trial listing → -
Status unknown NCT NCT00517257
Atorvastatin for the Treatment of Retinal Vein Occlusion
Not yet reported University of Toronto 180 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: Retinal Vein Occlusion, Retinal Vein Thrombosis, Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion, ThrombosisView official trial listing → -
Completed NCT NCT00519363
Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Not yet reported, Not yet reported The Center for Rheumatic Disease, Allergy, & Immunology 15 participants Est. completion 2008-12 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00529191
Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
Not yet reported Children's Hospital of Philadelphia 40 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00541697
Eze/Simva Switch Study in Diabetics (0653A-807)
Not yet reported Organon and Co 648 participants Est. completion 2005-10-14Type 2 diabetesView official trial listing → -
Completed NCT NCT00570752
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
Not yet reported Bristol-Myers Squibb 72 participants Est. completion 2010-12 17 sitesOther conditions: Vascular DiseasesView official trial listing → -
Completed NCT NCT00576576
Evaluation of Atorvastatin on Atherosclerosis Composition
Not yet reported Emory University 27 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00609063
The Effect of Statin Medications on Muscle Performance (The STOMP Study)
Not yet reported Hartford Hospital 420 participants Est. completion 2011-06 3 sites Stand-aloneOther conditions: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Muscular DiseasesView official trial listing → -
Completed NCT NCT00611143
Atorvastatin for Prevention of Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting Surgery
Not yet reported Samsung Medical Center 124 participants Est. completion 2007-05 1 site Stand-aloneOther conditions: Coronary Artery BypassView official trial listing → -
Completed NCT NCT00615823
Atorvastatin in Pulmonary Hypertension
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 220 participants Est. completion 2010-05 1 siteOther conditions: Hypertension, PulmonaryView official trial listing → -
Completed NCT NCT00616772
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
Not yet reported AbbVie (prior sponsor, Abbott) 682 participants Est. completion 2012-09 124 sites Stand-aloneCardiovascular disease Other conditions: Coronary Heart Disease, DyslipidemiaView official trial listing → -
Status unknown NCT NCT00620204
Efficacy Study of Atorvastatin to Treat Variant Angina
Not yet reported Samsung Medical Center 136 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Angina Pectoris, VariantView official trial listing → -
Completed NCT NCT00636766
Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
Not yet reported Aristotle University Of Thessaloniki 300 participants Est. completion 2009-01 1 site Stand-aloneCardiovascular diseaseType 2 diabetesMetabolic syndrome Other conditions: Carotid AtherosclerosisView official trial listing → -
Completed NCT NCT00637481
A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: Atypical Ductal Breast Hyperplasia, Breast Cancer, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in SituView official trial listing → -
Completed NCT NCT00639158
Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood
Not yet reported Abbott 543 participants 118 sitesOther conditions: Dyslipidemias, Coronary Heart Disease, Combined (Atherogenic) Dyslipidemia, Mixed DyslipidemiaView official trial listing → -
Terminated NCT NCT00640549
Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 41 participants Est. completion 2004-10 14 sitesType 2 diabetes Other conditions: Hyperlipidemia, Non-Insulin Dependent Diabetes MellitusView official trial listing → -
Completed NCT NCT00645151
A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 512 participants Est. completion 2005-02 33 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT00650689
Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
Not yet reported Organon and Co 122 participants Est. completion 2004-12 Stand-aloneCardiovascular disease Other conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Completed NCT NCT00651404
Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)
Not yet reported Organon and Co 137 participants Est. completion 2004-12 Stand-aloneOther conditions: Hypercholesterolemia, AtherosclerosisView official trial listing → -
Completed NCT NCT00653965
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
Not yet reported AstraZeneca 3000 participants Est. completion 2005-02Other conditions: Hypercholesterolemia, DyslipidaemiaView official trial listing → -
Completed NCT NCT00654485
COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects
Not yet reported AstraZeneca 940 participants Est. completion 2005-02Metabolic syndromeView official trial listing → -
Terminated NCT NCT00663234
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia
Not yet reported, Not yet reported International Maternal Pediatric Adolescent AIDS Clinical Trials Group 28 participants Est. completion 2014-12 11 sites Stand-aloneOther conditions: HIV Infections, HyperlipidemiaView official trial listing → -
Completed NCT NCT00664846
Standard Medical Management in Secondary Prevention of Ischemic Stroke in China
Not yet reported Peking Union Medical College Hospital 4000 participants Est. completion 2011-04 46 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00666029
Implications for Treatment of the Metabolic Syndrome
Not yet reported University Hospital Southampton NHS Foundation Trust 40 participants Est. completion 2008-02Metabolic syndromeView official trial listing → -
Terminated NCT NCT00669695
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
Not yet reported University Hospital, Grenoble 54 participants Est. completion 2013-02 4 sitesObstructive sleep apneaView official trial listing → -
Completed NCT NCT00673660
Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 375 participants Est. completion 2009-10 5 sitesOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00678184
The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake
Not yet reported Regional Hospital Holstebro 23 participants Est. completion 2007-10 2 sitesOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT00681525
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
Not yet reported Abbott 18 participants 1 site Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT00683618
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
Not yet reported AstraZeneca 934 participants Est. completion 2009-07 6 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00687076
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Not yet reported Baylor College of Medicine 102 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT00689442
Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
Not yet reported Akros Pharma Inc. 105 participants Est. completion 2006-03 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00690443
Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia
Not yet reported Aegerion Pharmaceuticals, Inc. 44 participants Est. completion 2008-09 5 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00715273
Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
Not yet reported University of Washington 217 participants Est. completion 2019-03-01 4 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery Diseases, AtherosclerosisView official trial listing → -
Completed NCT NCT00718796
Naturopathic Treatment for the Prevention of Cardiovascular Disease
Not yet reported The Canadian College of Naturopathic Medicine 300 participants Est. completion 2009-10 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00722956
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
Not yet reported AstraZeneca 12 participants Est. completion 2008-08 1 site Stand-aloneOther conditions: Healthy Volunteers, PharmacokineticsView official trial listing → -
Completed NCT NCT00728910
Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (CENTAUR): A Feasibility Study
Not yet reported University of Pennsylvania 25 participants Est. completion 2009-08 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00730132
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)
Organon and Co 712 participants Est. completion 2009-08Other conditions: Coronary Heart Disease, HypercholesterolemiaView official trial listing → -
Completed NCT NCT00739999
8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 39 participants Est. completion 2009-05 3 sitesOther conditions: Pediatric Heterozygous HypercholesterolemiaView official trial listing → -
Completed NCT NCT00741078
Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of Hypertension
Not yet reported Gachon University Gil Medical Center Est. completion 2008-08 1 site Stand-aloneOther conditions: HypertensionView official trial listing → -
Terminated NCT NCT00741715
Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Not yet reported Sanofi 1736 participants Est. completion 2009-06 2 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00756886
Does Atorvastatin Prevent Post Operative Atrial Fibrillation After Pulmonary Resection: A Randomized Clinical Study
Not yet reported University of Alabama at Birmingham 73 participants Est. completion 2011-05 1 siteOther conditions: ArrhythmiaView official trial listing → -
Completed NCT NCT00758004
Bioequivalence Study Of Pediatric Appropriate Formulation
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2009-03 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00767130
DNA Diagnostic System for Statin Safety and Efficacy
Genomas, Inc 750 participants Est. completion 2009-12 3 sitesOther conditions: Hypercholesterolemia, MyopathyView official trial listing → -
Terminated NCT NCT00767572
Statins and Endothelial Function in Patients With Coarctation of the Aorta
Not yet reported University of California, San Francisco 12 participants Est. completion 2010-07 1 site Stand-aloneOther conditions: Coarctation of the AortaView official trial listing → -
Completed NCT NCT00768638
Study of Atorvastatin Dose Dependent Reduction of Proteinuria
Not yet reported Laval University 23 participants Est. completion 2014-06 1 siteChronic kidney diseaseView official trial listing → -
Completed NCT NCT00770575
Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease
Not yet reported Takeda 148 participants Est. completion 2006-10 Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00770679
Effects of Statins on Lower Extremity Arterial Function Assessed by Magnetic Resonance Imaging
Not yet reported Johns Hopkins University 16 participants Est. completion 2012-07 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00770796
Statins for Prevention of Contrast Induced Nephropathy
Not yet reported Ospedale Misericordia e Dolce 304 participants Est. completion 2008-03Other conditions: Contrast Induced NephropathyView official trial listing → -
Completed NCT NCT00772564
The Use of Statins for Myocardial Death Prevention
Not yet reported Rambam Health Care Campus 25 participants Est. completion 2010-08 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00791648
Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery
Not yet reported Vanderbilt University Medical Center 653 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Acute Kidney Injury, Post-Operative Delirium, Icu Delirium, Acute Renal Failure, DeliriumView official trial listing → -
Completed NCT NCT00804843
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 100 participants Est. completion 2010-10 Stand-aloneOther conditions: Carotid AtherosclerosisView official trial listing → -
Completed NCT NCT00814255
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
Not yet reported NYU Langone Health 32 participants Est. completion 2014-02 18 sitesOther conditions: Focal Segmental GlomerulosclerosisView official trial listing → -
Status unknown NCT NCT00818103
Characteristic Study on Chinese Patients With Multiple Sclerosis
Not yet reported Sun Yat-sen University 600 participants Est. completion 2016-01 1 site Stand-aloneOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00827606
Atorvastatin Three Year Pediatric Study
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 272 participants Est. completion 2013-10 40 sites Stand-aloneOther conditions: Familial HypercholesterolemiaView official trial listing → -
Completed NCT NCT00844376
Bioavailability Study for New Atorvastatin Formulation
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 12 participants Est. completion 2008-03 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00861861
Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol (HDL-C) and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease (CAD)
Not yet reported Kumamoto University 129 participants Est. completion 2013-10 1 siteCardiovascular disease Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00864643
Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia
Not yet reported Takeda 172 participants Est. completion 2005-02 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00902967
Study To Check The Analgesic And Anti-Inflammatory Effects Of Atorvastatin In Patients Undergoing Abdominal Surgery
Not yet reported B. J. Medical College, Pune 40 participants Est. completion 2010-02 1 siteOther conditions: Abdominal SurgeryView official trial listing → -
Completed NCT NCT00917579
Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2008-09 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT00917644
Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 76 participants Est. completion 2008-09 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT00920101
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
Not yet reported National Defense Medical College, Japan 30 participants Est. completion 2013-12 1 siteOther conditions: Atherosclerosis, InflammationView official trial listing → -
Completed NCT NCT00926614
Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba
Not yet reported Brooke Army Medical Center 20 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Hepatitis cView official trial listing → -
Withdrawn NCT NCT00932048
Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
Not yet reported Korea University Est. completion 2012-03 1 site Stand-aloneType 2 diabetes Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00944827
Combination Treatment With Green Tea Extract and Statins in Patients With Hypercholesterolemia
Not yet reported University of Thessaly 40 participants Est. completion 2009-10 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Terminated NCT NCT00965055
Ezetimibe in Patients Hypo-responsive to Statins
Not yet reported University of California, San Diego 2 participants Est. completion 2012-09 1 site Stand-aloneCardiovascular disease Other conditions: High CholesterolView official trial listing → -
Completed NCT NCT00965185
Statin Therapy to Improve Atherosclerosis in HIV Patients
Not yet reported Massachusetts General Hospital 40 participants Est. completion 2014-01 1 site Stand-aloneCardiovascular disease Other conditions: HIV, Atherosclerosis, Inflammation, Statins, HMG-CoA, HIV InfectionsView official trial listing → -
Withdrawn NCT NCT00973271
Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
Not yet reported Essentialis, Inc. Est. completion 2011-12 Stand-aloneOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT00977288
A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029)
Not yet reported Merck Sharp & Dohme LLC 408 participants Est. completion 2014-04 Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Terminated NCT NCT00979940
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
Not yet reported Indiana University 60 participants Est. completion 2014-08 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00987974
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
Not yet reported Radboud University Medical Center 48 participants Est. completion 2010-03 1 siteOther conditions: Ischemia Reperfusion Injury, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT00990808
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2011-07 Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT00991705
A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
Not yet reported Boryung Pharmaceutical Co., Ltd 28 participants Est. completion 2009-09Other conditions: Essential HypertensionView official trial listing → -
Completed NCT NCT00993915
Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 687 participants Est. completion 2011-12Cardiovascular diseaseView official trial listing → -
Completed NCT NCT01013103
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
Not yet reported Hippocration General Hospital 72 participants Est. completion 2012-02 1 siteCardiovascular disease Other conditions: HMG-CoA Reductase Inhibitor Toxicity, Atherosclerosis, Oxidative Stress, Endothelial DysfunctionView official trial listing → -
Terminated NCT NCT01013870
Mission Connect Mild Traumatic Brain Injury (TBI) Integrated Clinical Protocol
Not yet reported Baylor College of Medicine 52 participants Est. completion 2015-06 2 sites Stand-aloneOther conditions: Traumatic Brain Injury, Post-traumatic Stress DisorderView official trial listing → -
Status unknown NCT NCT01033058
Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
Not yet reported Beijing Chao Yang Hospital 500 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: STEMIView official trial listing → -
Completed NCT NCT01041729
Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease
Not yet reported Hospital Universitario Getafe 60 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT01047501
Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)
Not yet reported Amarin Pharma Inc. 702 participants Est. completion 2011-02 80 sitesOther conditions: HypertriglyceridemiaView official trial listing → -
Completed NCT NCT01078285
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 500 participants Est. completion 2011-11 3 sitesOther conditions: Medication Non-AdherenceView official trial listing → -
Status unknown NCT NCT01086020
Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
Not yet reported Shanghai Jiao Tong University School of Medicine 400 participants Est. completion 2012-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01096875
Effects of Atorvastatin on Endothelial Progenitor Cells After Coronary Surgery
Not yet reported Ankara University 60 participants Est. completion 2010-10 1 siteOther conditions: Coronary Artery Bypass Surgery, Elective Surgical ProcedureView official trial listing → -
Completed NCT NCT01111656
Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b
Not yet reported Insel Gruppe AG, University Hospital Bern 28 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: Relapsing-remitting Multiple SclerosisView official trial listing → -
Completed NCT NCT01127945
Study to Evaluate the Effectiveness of High Dose Statin Loading in Acute Heart Failure Patients
Not yet reported Yonsei University 50 participants Est. completion 2013-11 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT01138072
A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Not yet reported GlaxoSmithKline 14 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: Infection, Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT01154036
MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162)
Not yet reported Organon and Co 1547 participants Est. completion 2012-10 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01166633
Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia
Not yet reported JW Pharmaceutical 200 participants Est. completion 2011-02Other conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01200056
Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
Not yet reported Prof. Stephen Lee 40 participants Est. completion 2010-06 1 siteOther conditions: Coronary Disease, Ultrasonography, Interventional, Hydroxymethylglutaryl-CoA Reductase InhibitorsView official trial listing → -
Completed NCT NCT01213498
The Effects of Atorvastatin on the Nitric Oxide-system in Patients With Non-diabetic Nephropathy
Not yet reported Erling Bjerregaard Pedersen 25 participants Est. completion 2012-01 1 siteCardiovascular disease Other conditions: NephropathyView official trial listing → -
Completed NCT NCT01223586
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
Kyoto University 238 participants Est. completion 2011-05 2 sitesOther conditions: Statin, Coronary Plaque, Acute Coronary Syndrome, Intravascular Ultrasound, Cardiovascular EventsView official trial listing → -
Completed NCT NCT01236430
A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551)
Not yet reported Organon and Co 200 participants Est. completion 2012-02 Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT01245608
Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
Not yet reported Tehran University of Medical Sciences 2400 participants Est. completion 2018-09 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01255852
Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting
Not yet reported Jinling Hospital, China 100 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: CVDView official trial listing → -
Completed NCT NCT01259791
Evaluation of Patients With Statin Myopathy Using an N of 1 Trial Design
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: Statin MyopathyView official trial listing → -
Completed NCT NCT01278459
Can Atorvastatin Improve Vascular Function in Women With a History of Preeclampsia?
Not yet reported University of Oxford 11 participants Est. completion 2012-04 1 site Stand-aloneOther conditions: Pre-EclampsiaView official trial listing → -
Completed NCT NCT01279590
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)
Not yet reported Furiex Pharmaceuticals, Inc 282 participants Est. completion 2011-11 67 sitesOther conditions: Myalgia, Hypercholesterolemia, HyperlipidemiaView official trial listing → -
Completed NCT NCT01293097
Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI
Not yet reported Peking University First Hospital 2884 participants Est. completion 2011-10 1 siteCardiovascular disease Other conditions: Unstable Angina Pectoris, Stable Angina PectorisView official trial listing → -
Completed NCT NCT01299181
A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis
Not yet reported University of Edinburgh 60 participants Est. completion 2013-08 1 siteOther conditions: BronchiectasisView official trial listing → -
Completed NCT NCT01304641
Cardiovascular Events Based On Statin Initiation In The Elderly
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 31603 participants Est. completion 2011-02Other conditions: Cardiovascular, DyslipidemiaView official trial listing → -
Completed NCT NCT01305317
Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients
Not yet reported Hormozgan University of Medical Sciences 74 participants Est. completion 2010-01 1 site Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT01318564
Diabetic Treatment Adherence
M.D. Anderson Cancer Center 28 participants Est. completion 2016-08 2 sitesOther conditions: Endocrine System DiseasesView official trial listing → -
Completed NCT NCT01351025
Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells
Not yet reported Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 98 participants Est. completion 2014-05 31 sites Stand-aloneOther conditions: HIV-1 InfectionView official trial listing → -
Completed NCT NCT01370590
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
Not yet reported Organon and Co 406 participants Est. completion 2012-04 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01375075
A Study of LY2484595 in Japanese Subjects
Not yet reported Eli Lilly and Company 165 participants Est. completion 2012-03 5 sites Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Withdrawn NCT NCT01442428
Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial
Not yet reported, Not yet reported University of Minnesota Est. completion 2016-06 3 sites Stand-aloneOther conditions: Immune Reconstitution Inflammatory Syndrome, Immune Reconstitution Syndrome, Tuberculosis, HIV-infection/AidsView official trial listing → -
Completed NCT NCT01442987
Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia
Not yet reported Hanmi Pharmaceutical Company Limited 230 participants Est. completion 2013-05 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01448174
Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
Not yet reported Poznan University of Medical Sciences 310 participants Est. completion 2014-10 1 siteMetabolic syndromeType 2 diabetes Other conditions: Renal Failure Chronic Requiring Hemodialysis, HyperlipidemiaView official trial listing → -
Completed NCT NCT01448642
Statins Evaluation in Coronary Procedures and Revascularization Trial
Not yet reported Hospital do Coracao 4191 participants Est. completion 2018-04 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT01455935
Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention
Not yet reported Jacobs Neurological Institute 90 participants Est. completion 2014-02 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01477853
A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
Not yet reported Merck Sharp & Dohme LLC 166 participants Est. completion 2012-12-04 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01497912
Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes
Not yet reported Karolinska Institutet 20 participants Est. completion 2010-01 1 siteOther conditions: Type 1 Diabetes Mellitus, DyslipidemiaView official trial listing → -
Status unknown NCT NCT01503671
Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients
Not yet reported National Taiwan University Hospital 36 participants Est. completion 2015-10 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT01516879
Durable Effect of PCSK9 Antibody CompARed wiTh placEbo Study
Not yet reported Amgen 905 participants Est. completion 2013-10-14 96 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01518166
Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH
Not yet reported Novo Nordisk A/S 70 participants Est. completion 2007-04 1 site Added to GLP-1Other conditions: Diabetes, HealthyView official trial listing → -
Completed NCT NCT01525407
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Not yet reported Fred Hutchinson Cancer Center 83 participants Est. completion 2016-02 3 sites Stand-aloneOther conditions: Malignant NeoplasmView official trial listing → -
Completed NCT NCT01527045
Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies
Not yet reported Fred Hutchinson Cancer Center 47 participants Est. completion 2019-04 2 sites Stand-aloneOther conditions: Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia, Loss of Chromosome 17p, Myelodysplastic/Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Aggressive Adult Non-Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Waldenstrom MacroglobulinemiaView official trial listing → -
Completed NCT NCT01541943
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
Not yet reported HanAll BioPharma Co., Ltd. 356 participants Est. completion 2014-11 1 siteOther conditions: Essential Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT01544309
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
Not yet reported Listen Trial Group 1049 participants 133 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT01548326
Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine
Not yet reported Nematollah Jonaidi Jafari 52 participants Est. completion 2012-07 1 siteOther conditions: Hepatitis B, Vaccination FailureView official trial listing → -
Status unknown NCT NCT01550419
Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
Not yet reported Shanghai Minhang Central Hospital 100 participants Est. completion 2014-02 1 site Stand-aloneCardiovascular disease Other conditions: Ventilator-associated PneumoniaView official trial listing → -
Withdrawn NCT NCT01555632
Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy
Not yet reported University of Nebraska Est. completion 2013-02 Stand-aloneOther conditions: Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT01567826
Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy
Not yet reported Annapoorna Kini 87 participants Est. completion 2012-02 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01569100
Atorvastatin After Aneurysmal Subarachnoid Hemorrhage
Groupe Hospitalier Pitie-Salpetriere 278 participants Est. completion 2007-12Other conditions: SAHView official trial listing → -
Status unknown NCT NCT01572623
Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
Not yet reported Campus Bio-Medico University 150 participants Est. completion 2012-09 1 siteOther conditions: Carotid StenosisView official trial listing → -
Completed NCT NCT01581476
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Not yet reported University of Cambridge 443 participants Est. completion 2017-06 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Withdrawn NCT NCT01605344
Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
Not yet reported UNC Lineberger Comprehensive Cancer Center Est. completion 2014-07 1 site Stand-aloneOther conditions: Advanced Adenocarcinoma of the Colon or RectumView official trial listing → -
Status unknown NCT NCT01617538
Application of Contrast Enhance Ultrasound to Evaluate Hemodynamics Change in MCA With Moderate to Severe Stenosis
Not yet reported, Not yet reported Capital Medical University 30 participants Est. completion 2013-09 1 site Stand-aloneOther conditions: StenosisView official trial listing → -
Status unknown NCT NCT01617772
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis
Not yet reported Tehran University of Medical Sciences 440 participants Est. completion 2019-12 2 sites Stand-aloneOther conditions: Non-alcoholic SteatohepatitisView official trial listing → -
Completed NCT NCT01623115
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy
Not yet reported Sanofi 486 participants Est. completion 2014-12 91 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01624207
The Efficacy and Safety of Atorva® 20mg Versus Lipitor® 20mg
Not yet reported Seoul National University Hospital 376 participants Est. completion 2011-04 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01633359
The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients
Not yet reported Ji Huang 300 participants Est. completion 2013-05 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01634906
Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
Not yet reported Sint Franciscus Gasthuis 55 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Hyperlipidemia, AtherosclerosisView official trial listing → -
Completed NCT NCT01635946
Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin
Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Atorvastatin, Healthy VolunteersView official trial listing → -
Completed NCT NCT01644175
Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)
Not yet reported Sanofi 316 participants Est. completion 2014-04 76 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01645384
Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 69 participants Est. completion 2009-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01645410
Bioequivalence Study of Atorvastatin Calcium Tablets, 40 mg of Dr. Reddy's Under Fed Conditions
Not yet reported Dr. Reddy's Laboratories Limited 71 participants Est. completion 2009-05 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01645423
Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fed Conditions
Not yet reported Dr. Reddy's Laboratories Limited 77 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01645449
Bioequivalence Study of Atorvastatin Calcium Tablets, 80 mg of Dr. Reddy's Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 77 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01660191
A Study Comparing CoQ10 Levels While Taking 3 Different Statins
Not yet reported University of Kansas Medical Center 134 participants Est. completion 2013-10 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01665235
Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery Stenosis
Not yet reported RenJi Hospital 200 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Blood Pressure Variability, Intracranial Artery StenosisView official trial listing → -
Completed NCT NCT01673178
Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus
Not yet reported Pfizer 107 participants Est. completion 2013-09 17 sitesOther conditions: Diabetes Melliuts, Type 2View official trial listing → -
Completed NCT NCT01686230
Acupuncture in Patients With Stable Angina Pectoris
Not yet reported Chengdu University of Traditional Chinese Medicine 404 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Angina, StableView official trial listing → -
Completed NCT NCT01692717
Clinical Assessment Of Association Pharmacokinetics Atorvastatin + Losartana + Hydrochlorothiazide
Not yet reported Azidus Brasil 90 participants Est. completion 2013-05-31 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Terminated NCT NCT01697735
The Therapeutic Effects of Statins and Berberine on the Hyperlipemia
Not yet reported Wenzhou Medical University 24 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT01700075
Physical and Chemical Study of Atherosclerosis Mechanisms
Not yet reported Nazarbayev University 97 participants Est. completion 2011-12 1 siteCardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis of Femoral ArteryView official trial listing → -
Completed NCT NCT01710007
Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia
Not yet reported Orient Pharma Co., Ltd. 202 participants Est. completion 2012-11 8 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01730040
Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)
Not yet reported Regeneron Pharmaceuticals 355 participants Est. completion 2014-05 97 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01732718
Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease
Not yet reported University of North Carolina, Chapel Hill 13 participants Est. completion 2018-01-09 1 site Stand-aloneOther conditions: Sickle Cell Disease, Sickle Cell NephropathyView official trial listing → -
Completed NCT NCT01748279
The Effects of Atorvastatin Treatment in COPD Patients
Not yet reported Medical University of Bialystok 18 participants Est. completion 2013-04 1 siteOther conditions: COPDView official trial listing → -
Completed NCT NCT01759836
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer
Not yet reported Asan Medical Center 364 participants Est. completion 2021-09-30 1 site Stand-aloneOther conditions: Prostatic NeoplasmsView official trial listing → -
Status unknown NCT NCT01761656
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
Not yet reported Central South University 180 participants Est. completion 2014-02 1 site Stand-aloneCardiovascular disease Other conditions: Stable Angina, Unstable AnginaView official trial listing → -
Completed NCT NCT01768481
Intima Media Thickness Regression in Dyslipidemic Teenagers
Not yet reported Université de Montréal 16 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Obesity, DyslipidemiaView official trial listing → -
Completed NCT NCT01770210
Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events
Elpen Pharmaceutical Co. Inc. 670 participants Est. completion 2014-07 17 sitesOther conditions: Cardiovascular DisordersView official trial listing → -
Completed NCT NCT01779687
Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
Not yet reported Radboud University Medical Center 24 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: HIV, HypercholesterolaemiaView official trial listing → -
Terminated NCT NCT01837069
Risk Factor Control Before Orthopedic Surgery
Not yet reported NYU Langone Health 198 participants Est. completion 2018-04-02 1 siteOsteoarthritisCardiovascular diseaseView official trial listing → -
Completed NCT NCT01856374
Serial EValuation of multiplE Coronary Artery Diseases by an Optical Coherence Tomography; Assessment of the Changes of de Novo Lesions and Comparisons of Neointimal Coverage Between Xience Prime® Versus Cypher SelectTM Stents; SEVEN-Xience Study
Not yet reported Yonsei University 60 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: Multi-vessel Diseases, AnginaView official trial listing → -
Terminated NCT NCT01863225
Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
Not yet reported Resverlogix Corp 13 participants Est. completion 2013-06 1 site Stand-aloneCardiovascular disease Other conditions: DyslipidemiaView official trial listing → -
Status unknown NCT NCT01925937
Atorvastatin/CoenzymeQ10 in Congestive Heart Failure
Not yet reported Isfahan University of Medical Sciences 30 participants 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT01926782
Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)
Not yet reported Regeneron Pharmaceuticals 803 participants Est. completion 2015-04 83 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01929135
Short-term Effect of 2% Atorvastatin Dentifrice in Periodontal Status.
Not yet reported Universidad de los Andes, Chile 38 participants Est. completion 2014-06 2 sites Stand-aloneOther conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT01936103
Effects of Intensive Statin Treatment on Left Ventricular Function
Not yet reported Shenyang Northern Hospital 120 participants Est. completion 2014-07 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01946815
Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease
Not yet reported Keimyung University Dongsan Medical Center 119 participants Est. completion 2018-11 4 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01954394
Open Label Study of Long Term Safety Evaluation of Alirocumab
Not yet reported Sanofi 986 participants Est. completion 2017-06-30 177 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT01956201
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Not yet reported Chong Kun Dang Pharmaceutical 476 participants Est. completion 2016-08 30 sites Stand-aloneOther conditions: Mixed HyperlipidemiaView official trial listing → -
Completed NCT NCT01964326
Actual Use Trial of Atorvastatin Calcium 10 mg
Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1311 participants Est. completion 2014-12 37 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT01970215
TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP)
Not yet reported Xention Ltd 364 participants Est. completion 2014-07 17 sitesOther conditions: DyslipidemiaView official trial listing → -
Terminated NCT NCT01972178
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Not yet reported Pronova BioPharma 113 participants Est. completion 2014-08 29 sites Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT01988571
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
Not yet reported Wake Forest University Health Sciences 279 participants Est. completion 2020-09-24 51 sitesOther conditions: Breast Cancer, LymphomaView official trial listing → -
Status unknown NCT NCT02023892
Single Dose of Atorvastatin and Circulating Endothelial Microparticles
Not yet reported Sun Yat-sen University 30 participants Stand-aloneOther conditions: Endothelium, Hydroxymethylglutaryl-CoA Reductase InhibitorsView official trial listing → -
Completed NCT NCT02029118
Acupoint Application in Patients With Stable Angina Pectoris (AASAP)
Not yet reported Chengdu University of Traditional Chinese Medicine 200 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: Stable Angina PectorisView official trial listing → -
Completed NCT NCT02029573
Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
Not yet reported King Fahad Medical City 36 participants Est. completion 2016-12-31 1 site Stand-aloneOther conditions: Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT02080455
Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.
Not yet reported Aegerion Pharmaceuticals, Inc. 32 participants Est. completion 2014-03-07 1 site Stand-aloneOther conditions: Effect of Atorvastatin on the Pharmacokinetics of LomitapideView official trial listing → -
Completed NCT NCT02084069
Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair
Not yet reported Urmia University of Medical Sciences 58 participants Est. completion 2014-04 1 siteOther conditions: Heart Valve DiseasesView official trial listing → -
Completed NCT NCT02089061
Drug Interaction Statin
Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2014-05 Stand-aloneOther conditions: Acute Coronary SyndromesView official trial listing → -
Completed NCT NCT02097589
The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23
Not yet reported University of Florida 33 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Healthy ControlsView official trial listing → -
Completed NCT NCT02098460
To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
Not yet reported Otsuka Beijing Research Institute 300 participants Est. completion 2016-03 1 siteOther conditions: Severe HypercholesterolemiaView official trial listing → -
Completed NCT NCT02107898
Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)
Not yet reported Sanofi 216 participants Est. completion 2015-09 32 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02113540
Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
Not yet reported Isfahan University of Medical Sciences 1 site Stand-aloneOther conditions: Contrast Induced NephropathyView official trial listing → -
Completed NCT NCT02119520
PLATELET RICH FIBRIN COMBINED WITH 1.2% ATORVASTATIN FOR TREATMENT OF INTRABONY DEFECTS IN CHRONIC PERIODONTITIS
Not yet reported Government Dental College and Research Institute, Bangalore 96 participants Est. completion 2014-02 1 siteOther conditions: PeriodontitisView official trial listing → -
Completed NCT NCT02133807
Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis
Not yet reported Russian Cardiology Research and Production Center 32 participants Est. completion 2012-06 1 site Stand-aloneOther conditions: Atherosclerosis, Coronary Disease, Carotid Artery DiseasesView official trial listing → -
Completed NCT NCT02155530
COmparison and Modification in Neointimal Pattern Assessed by Optical Coherence Tomography With High Versus Moderate Efficacy Statin Treatment After Drug Eluting Stent Implantation: COMPASS Trial
Not yet reported Yonsei University 30 participants Est. completion 2016-06 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02157337
The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery
Not yet reported Yonsei University 23 participants Est. completion 2015-05-29 1 site Stand-aloneOther conditions: Aortic Surgery, Acute Kidney InjuryView official trial listing → -
Completed NCT NCT02160743
The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects
Not yet reported HK inno.N Corporation 28 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Food Effect Study of CJ-30056 20mg/500mgView official trial listing → -
Completed NCT NCT02171039
Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers
Not yet reported Boehringer Ingelheim 24 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02189837
Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody
Not yet reported Amgen 89 participants Est. completion 2015-03-05 2 sites Stand-aloneOther conditions: Primary Hyperlipidemia and Mixed DyslipidemiaView official trial listing → -
Completed NCT NCT02197065
Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Not yet reported Hospital for Special Surgery, New York 20 participants Est. completion 2017-01 2 sites Stand-aloneOther conditions: Hip Fracture, Myocardial Ischemia, InflammationView official trial listing → -
Status unknown NCT NCT02219191
Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases
Not yet reported Chengdu PLA General Hospital 150 participants Est. completion 2018-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02225834
Atorvastatin in Acute Stroke Treatment
Not yet reported University of Palermo 50 participants Est. completion 2014-03 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT02227784
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Not yet reported Eli Lilly and Company 366 participants Est. completion 2015-12 64 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02245269
Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers
Not yet reported Boehringer Ingelheim 23 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02286544
Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers
Not yet reported Karolinska Institutet 36 participants Est. completion 2015-12 1 site Stand-aloneCardiovascular disease Other conditions: Inflammation, Acute Coronary Syndrome (ACS), Reperfusion InjuryView official trial listing → -
Completed NCT NCT02288338
CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
Not yet reported Chong Kun Dang Pharmaceutical 36 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02289963
Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and Taiwan
Not yet reported Sanofi 199 participants Est. completion 2016-04 27 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02295046
Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition
Not yet reported Dr. Reddy's Laboratories Limited 80 participants Est. completion 2011-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02305355
Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and Hypertriglyceridemia
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 68 participants Est. completion 2011-02 1 site Stand-aloneType 2 diabetes Other conditions: HypertriglycemiaView official trial listing → -
Completed NCT NCT02314208
Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 12 participants Est. completion 2018-01-01 1 siteOther conditions: Spastic Paraplegia, HereditaryView official trial listing → -
Status unknown NCT NCT02323425
Effects of Limb Ischemic Postconditioning in Young sICAS
Not yet reported Xi'an Jiaotong University 100 participants Est. completion 2018-03 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02342015
Effect of Atorvastatin on Bone-vascular Axis
Not yet reported University of Padova 20 participants Est. completion 2014-03 Stand-aloneOther conditions: Osteoporosis, HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT02350959
Adverse Plaque Characteristics in CCTA and TVC Imaging
Not yet reported National Health Insurance Service Ilsan Hospital 100 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: PlaqueView official trial listing → -
Completed NCT NCT02363725
Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response
Not yet reported University Hospital, Montpellier 44 participants Est. completion 2016-08 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02364258
Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients
Not yet reported Children's Mercy Hospital Kansas City 28 participants Est. completion 2017-12-27 1 site Stand-aloneOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02370784
Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Not yet reported Robyn T. Domsic, MD, MPH 24 participants Est. completion 2019-12-15 1 siteOther conditions: SclerodermaView official trial listing → -
Completed NCT NCT02374047
A 2-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of CAT-2054 in Healthy Subjects
Not yet reported Catabasis Pharmaceuticals 118 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02386033
Atorvastatin in the Treatment of Mandibular Degree II Furcation Defects
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 60 participants Est. completion 2014-07Other conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT02392416
Atorvastatin Study in Cardiovascular Disease Risk
Elpen Pharmaceutical Co. Inc. 900 participants Est. completion 2016-02 2 sitesOther conditions: Hypercholesterolemia, DyslipidemiaView official trial listing → -
Status unknown NCT NCT02411903
The Dynamic Effect of Non-cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized and Cytochrome P450 Isoenzyme 3A4（CYP3A4）-Metabolized Statins on Clopidogrel Resistance in Patients With Cerebral Infarction
Not yet reported The Third Affiliated Hospital of Guangzhou Medical University 160 participants Est. completion 2016-08Other conditions: Cerebral Infarction, Clopidogrel,Poor Metabolism of (Disorder)View official trial listing → -
Status unknown NCT NCT02416427
Targeting the Hippo Transducer TAZ in Breast Cancer With Statins
Not yet reported Regina Elena Cancer Institute 78 participants Est. completion 2016-12 Stand-aloneOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02451098
Clinical Trial to Evaluate the Efficacy and Safety of CKD-391
Not yet reported Chong Kun Dang Pharmaceutical 385 participants Est. completion 2016-01 1 siteOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02455869
Comparison of Alendronate With Atorvastatin in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 104 participants Est. completion 2015-03Other conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT02458755
Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis
Not yet reported Samsung Medical Center 80 participants Est. completion 2018-06 1 site Stand-aloneCardiovascular disease Other conditions: Intracranial AtherosclerosisView official trial listing → -
Completed NCT NCT02461004
CKD-391 Pharmacokinetic Study
Not yet reported Chong Kun Dang Pharmaceutical 52 participants Est. completion 2015-10 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02470455
Effect of Atorvastatin on Glycemic Control in Prediabetic Patients
Shri Ramachandra Bhanj Medical College 75 participants Est. completion 2012-12 1 siteOther conditions: Prediabetic StateView official trial listing → -
Completed NCT NCT02518503
High Potency Statins and the Risk of Diabetes
Canadian Network for Observational Drug Effect Studies, CNODES 136966 participants Est. completion 2013-02Type 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02549846
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
Not yet reported Hyogo Medical University 270 participants Est. completion 2017-03 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02550288
A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383)
Not yet reported Organon and Co 309 participants Est. completion 2016-05-30 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02566187
A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet
Not yet reported Boryung Pharmaceutical Co., Ltd 99 participants Est. completion 2015-10 1 siteOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Completed NCT NCT02579356
To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers
Not yet reported Samil Pharmaceutical Co., Ltd. 48 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Diseases of the Circulatory System, Essential HypertensionView official trial listing → -
Completed NCT NCT02586155
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Not yet reported Resverlogix Corp 2425 participants Est. completion 2021-06-21 214 sites Stand-aloneType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02590653
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
Not yet reported Penza State University 200 participants Est. completion 2020-02 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02591836
Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients as Monotherapy or in Combination With Atorvastatin
Not yet reported NeuroBo Pharmaceuticals Inc. 277 participants Est. completion 2003-06 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT02596126
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Not yet reported Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III 2499 participants Est. completion 2022-03-31 113 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02600520
Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 45 participants Est. completion 2015-05Other conditions: Chronic PeriodontitisView official trial listing → -
Status unknown NCT NCT02609711
Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects
Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 90 participants 1 siteOther conditions: Healthy Male SubjectsView official trial listing → -
Completed NCT NCT02641899
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
Not yet reported Intarcia Therapeutics 33 participants Est. completion 2016-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02651753
A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
Not yet reported Chong Kun Dang Pharmaceutical 48 participants Est. completion 2016-05Other conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT02659397
A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg
Not yet reported Esperion Therapeutics, Inc. 68 participants Est. completion 2016-07 19 sites Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02668016
Self-Assessment Method for Statin Side-effects Or Nocebo
Not yet reported Imperial College London 60 participants Est. completion 2020-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Adverse Effects, HyperlipidemiasView official trial listing → -
Completed NCT NCT02679261
Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve
Not yet reported Hospital Universitari Vall d'Hebron Research Institute 220 participants Est. completion 2021-02 10 sites Stand-aloneOther conditions: Bicuspid Aortic ValveView official trial listing → -
Completed NCT NCT02685462
Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and Digoxin
Not yet reported Tobira Therapeutics, Inc. 36 participants Est. completion 2016-02-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02706860
Efficacy of Different Perioperative Statin Regimens on the Protection Against Post Coronary Artery Bypass Grafting Major Adverse Cardio-cerebral Events
Not yet reported Cairo University 94 participants Est. completion 2015-02 Stand-aloneOther conditions: Coronary Artery Bypass GraftingView official trial listing → -
Status unknown NCT NCT02726555
The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin
Not yet reported Wenzhou Medical University 240 participants Est. completion 2026-05 1 site Stand-aloneOther conditions: Dyslipidemia, AtherosclerosisView official trial listing → -
Completed NCT NCT02749578
Drug Interaction Study of MGL-3196 With Atorvastatin
Not yet reported Madrigal Pharmaceuticals, Inc. 14 participants Est. completion 2016-05 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02776956
Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy
Not yet reported xieruiqin 180 participants Est. completion 2018-08 1 site Stand-aloneOther conditions: Atrial FibrillationView official trial listing → -
Completed NCT NCT02781064
STATIN: Web-based Investigation of Side Effects
Not yet reported London School of Hygiene and Tropical Medicine 200 participants Est. completion 2019-08-08 58 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02800174
Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis
Not yet reported Beijing Jishuitan Hospital 103 participants Est. completion 2008-06 Stand-aloneOther conditions: Carotid Artery StenosisView official trial listing → -
Terminated NCT NCT02819869
The Combination Effect of Statin Plus Metformin on Relapse-free
Not yet reported Taipei Medical University WanFang Hospital 3 participants Est. completion 2016-12-14 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Terminated NCT NCT02850081
Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes
Not yet reported Columbia University 31 participants Est. completion 2020-03-31 7 sites Stand-aloneCardiovascular disease Other conditions: Carotid Artery StenosisView official trial listing → -
Completed NCT NCT02901379
Effect of 80-mg Atorvastatin on Myocardial Edema
Not yet reported National Cardiovascular Center Harapan Kita Hospital Indonesia 40 participants Est. completion 2018-08 Stand-aloneOther conditions: Myocardial EdemaView official trial listing → -
Completed NCT NCT02910778
The Effect of Ticagrelor With or Without Atorvastatin on Endothelial Function in Healthy Males
Not yet reported Medical University of Vienna 32 participants Est. completion 2017-03 1 site Stand-aloneOther conditions: IschemiaView official trial listing → -
Completed NCT NCT02942602
Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
Not yet reported Yonsei University 58 participants Est. completion 2016-05-23 1 site Stand-aloneOther conditions: HyperlipidemiaView official trial listing → -
Completed NCT NCT02958852
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer
Not yet reported Lund University Hospital 126 participants Est. completion 2025-01-15 1 site Stand-aloneOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT03004001
Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome
Not yet reported Gloria Vega 3 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Nephrotic SyndromeView official trial listing → -
Withdrawn NCT NCT03047538
Fixed Combination for Lipid and Blood Pressure Control
Not yet reported Charles University, Czech Republic Est. completion 2019-12-31 1 siteOther conditions: Arterial Hypertension, Dyslipidemias, Blood Pressure, Lipid Metabolism DisordersView official trial listing → -
Status unknown NCT NCT03047772
Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients
Not yet reported Yuejin Yang 124 participants Est. completion 2018-12-31 Stand-aloneCardiovascular disease Other conditions: Stem Cell Transplantation, Angioplasty, Transluminal, Percutaneous CoronaryView official trial listing → -
Completed NCT NCT03051100
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
Not yet reported Esperion Therapeutics, Inc. 63 participants Est. completion 2017-07-05 11 sites Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Withdrawn NCT NCT03066466
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
Not yet reported Loyola University Est. completion 2021-02-28 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic SyndromeView official trial listing → -
Status unknown NCT NCT03072082
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization
Not yet reported Jun Li 440 participants Est. completion 2019-02 Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03072121
Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization
Not yet reported Jun Li 440 participants Est. completion 2019-02 Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03079115
High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting
Not yet reported Beijing Hospital 130 participants Est. completion 2020-04-30 1 siteOther conditions: Carotid Artery StenosisView official trial listing → -
Completed NCT NCT03110848
Effects of Atorvastatin in Graves' Orbitopathy (GO)
Not yet reported University of Pisa 88 participants Est. completion 2021-04-30 1 site Stand-aloneOther conditions: Thyroid Associated Ophthalmopathy, HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT03186404
Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study
Not yet reported University Health Network, Toronto 112 participants Est. completion 2023-12 1 site Stand-aloneHeart failure Other conditions: Cancer, CardiotoxicityView official trial listing → -
Completed NCT NCT03207698
PRF+1% MF for Class II Mandibular Furcation Defects
Not yet reported, Not yet reported Government Dental College and Research Institute, Bangalore 75 participants Est. completion 2016-05 1 siteOther conditions: Furcation DefectsView official trial listing → -
Completed NCT NCT03247400
The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo
Not yet reported, Not yet reported Nicolaus Copernicus University 24 participants Est. completion 2019-04-30 1 siteOther conditions: Non-segmental VitiligoView official trial listing → -
Completed NCT NCT03382756
A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337
Not yet reported Chong Kun Dang Pharmaceutical 16 participants Est. completion 2017-11-07 1 siteOther conditions: DyslipidemiasView official trial listing → -
Completed NCT NCT03391830
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
Not yet reported Mansoura University 250 participants Est. completion 2020-01-01 1 siteOther conditions: Contrast-induced Nephropathy, Statin, Ascorbic Acid, AKIView official trial listing → -
Active, not recruiting NCT NCT03417388
Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
Not yet reported Cedars-Sinai Medical Center 2476 participants Est. completion 2026-09-14 81 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03433196
Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases
Not yet reported Zhejiang Hisun Pharmaceutical Co. Ltd. 255 participants Est. completion 2018-10-10 Stand-aloneOther conditions: Hypercholesterolemia in Coronaory Heart DiseaseView official trial listing → -
Status unknown NCT NCT03438955
Phase I Drug-drug Interaction of Omega-3 and Atorvastatin
Not yet reported DongKoo Bio & Pharma 48 participants Est. completion 2018-08-31 1 siteOther conditions: Hyperlipidemia, HypertriglyceridemiaView official trial listing → -
Completed NCT NCT03482180
Evaluate the Efficacy and Safety of KI1106 in Patients Whose TG Level is Not Adequately Controlled With Atorvastatin Calcium Monotherapy While LDL-C is Properly Controlled
Not yet reported Kuhnil Pharmaceutical Co., Ltd. 215 participants Est. completion 2018-03-23Other conditions: DyslipidemiasView official trial listing → -
Status unknown NCT NCT03532620
China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
Not yet reported Jun Tao 396 participants Est. completion 2020-09 13 sitesOther conditions: Prediabetic State, Hypertension, DyslipidemiasView official trial listing → -
Status unknown NCT NCT03541109
A Polypill for Secondary Prevention of Ischemic Heart Disease
Not yet reported Isfahan University of Medical Sciences 1200 participants Est. completion 2024-08 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03570697
Imaging of Coronary Plaques in Participants Treated With Evolocumab
Not yet reported Amgen 164 participants Est. completion 2021-01-21 33 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03604471
Lipid-lowering Therapy Individualization
Not yet reported Université Catholique de Louvain 75 participants Est. completion 2019-08-27 1 siteOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT03610217
Pragmatic Clinical Trials in Scleroderma
Not yet reported University of West London 400 participants Est. completion 2021-10 1 site Stand-aloneOther conditions: Scleroderma, Systemic, Sclerosis, SystemicView official trial listing → -
Status unknown NCT NCT03610321
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
Not yet reported, Not yet reported First Affiliated Hospital of Harbin Medical University 70 participants Est. completion 2021-12-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03657472
Bioequivalence Study of CJ-30061 in Healthy Male Volunteers
Not yet reported HK inno.N Corporation 42 participants Est. completion 2016-11-09 1 site Stand-aloneOther conditions: Hypertension, HyperlipidemiaView official trial listing → -
Status unknown NCT NCT03692754
Atorvastatin in Management of Newly Diagnosed ITP
Not yet reported, Not yet reported Shandong University 30 participants Est. completion 2023-12-01 1 siteOther conditions: Immune Thrombocytopenia, Purpura, ThrombocytopenicView official trial listing → -
Status unknown NCT NCT03696940
Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population
Not yet reported Laboratorios Grossman, S.A. 120 participants Est. completion 2019-08-31 1 site Stand-aloneOther conditions: Dyslipidemias, Cardiovascular Risk FactorView official trial listing → -
Completed NCT NCT03768427
Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)
Not yet reported Organon and Co 454 participants Est. completion 2021-04-01 30 sitesOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03837925
Pharmaco-metabolomic Effects of Statins: METASTATINE
Not yet reported French Cardiology Society 120 participants Est. completion 2022-12-21 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03867110
An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)
Not yet reported Organon and Co 628 participants Est. completion 2001-07-27 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT03877783
DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes
Not yet reported Umeå University 10 participants Est. completion 2023-06-30 1 site Stand-aloneType 2 diabetes Other conditions: Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT03882892
Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)
Not yet reported Organon and Co 400 participants Est. completion 2002-08-08 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03882996
A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)
Not yet reported Organon and Co 432 participants Est. completion 2003-02-04 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Completed NCT NCT03885921
Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)
Not yet reported Organon and Co 44 participants Est. completion 2003-07-08 Stand-aloneOther conditions: HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT03956368
Efficacy of Atorvastatin in Chronic Subdural Haematoma
Not yet reported Chinese University of Hong Kong 690 participants Est. completion 2023-03-16 7 sites Stand-aloneOther conditions: Chronic Subdural HematomaView official trial listing → -
Completed NCT NCT03967496
Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic Factors
Sultan Qaboos University 402 participants Est. completion 2019-03-31 1 siteOther conditions: Delirium, Anesthesia; Adverse EffectView official trial listing → -
Status unknown NCT NCT03971019
Survival Benefits of Statins in Breast Cancer Patients
Not yet reported Peking Union Medical College Hospital 314 participants Est. completion 2024-06-28 1 site Stand-aloneOther conditions: Breast Cancer FemaleView official trial listing → -
Status unknown NCT NCT04026230
Impact of Atorvastatin on Prostate Cancer Progression During ADT
Not yet reported Tampere University Hospital 400 participants Est. completion 2025-12-31 10 sites Stand-aloneOther conditions: Metastatic Prostate Cancer, Recurrent Prostate CancerView official trial listing → -
Completed NCT NCT04047940
A Study of LY900020 in Healthy Chinese Participants
Not yet reported Eli Lilly and Company 32 participants Est. completion 2020-02-18 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT04056039
Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis.
Not yet reported Hospital Central "Dr. Ignacio Morones Prieto" 60 participants Est. completion 2019-06-30 1 siteCardiovascular disease Other conditions: Arthritis, RheumatoidView official trial listing → -
Status unknown NCT NCT04091412
Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion
Not yet reported The Second Hospital of Hebei Medical University 500 participants Est. completion 2020-05-01 1 site Stand-aloneOther conditions: Collateral Circulation, Large-artery Occlusion, Cerebral InfarctionView official trial listing → -
Active, not recruiting NCT NCT04111419
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
Not yet reported Shanghai Jiao Tong University School of Medicine 1200 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Atrial Fibrillation, HypertensionView official trial listing → -
Status unknown NCT NCT04149483
Statin Treatment for UnruptureD Intracranial anEurysms Study
Not yet reported Beijing Neurosurgical Institute 60 participants Est. completion 2021-02-01 1 site Stand-aloneOther conditions: Intracranial Aneurysm, Inflammation VascularView official trial listing → -
Status unknown NCT NCT04151355
Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis
Not yet reported Ain Shams University 100 participants Est. completion 2020-09-30 1 site Stand-aloneOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT04245046
Drug-drug-interaction Study of Candesartan, Amlodipine and Atorvastatin
Not yet reported Midas Pharma GmbH 18 participants Est. completion 2019-02-18 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT04251364
Treatment of Chronic Mountain Sickness
Not yet reported Centre d'Expertise sur l'Altitude EXALT 60 participants Est. completion 2021-12-30 1 site Stand-aloneOther conditions: Hypoxia, AltitudeView official trial listing → -
Completed NCT NCT04270370
A Study of LY3478045 in Healthy Participants
Not yet reported Eli Lilly and Company 72 participants Est. completion 2021-06-23 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT04306627
Effect of Atorvastatin on Carotid Intima Media Thickness
Not yet reported Yerevan State Medical University 200 participants Est. completion 2021-02-28Other conditions: Essential Hypertension, HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT04325009
Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"
Not yet reported Dong-A ST Co., Ltd. 56 participants Est. completion 2020-08 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT04379999
Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
Not yet reported Fox Chase Cancer Center 43 participants Est. completion 2025-08-04 1 siteOther conditions: Lynch SyndromeView official trial listing → -
Completed NCT NCT04453735
MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study
Not yet reported Vestre Viken Hospital Trust 27 participants Est. completion 2020-12-18 2 sitesOther conditions: Statin Adverse ReactionView official trial listing → -
Completed NCT NCT04472637
Atorvastatin Effects On Arterial Stiffness In Hemodialysis
Not yet reported Alexandria University 50 participants Est. completion 2021-07-01 1 site Stand-aloneOther conditions: Arterial StiffnessView official trial listing → -
Active, not recruiting NCT NCT04575857
Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression
University of Washington 100 participants Est. completion 2040-02 1 siteOther conditions: Rheumatic Heart Disease, Valvular DiseaseView official trial listing → -
Status unknown NCT NCT04581759
Endovascular Treatment and RIPC in Acute Ischemic Stroke
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-10-30 1 siteCardiovascular disease Other conditions: Endovascular TreatmentView official trial listing → -
Status unknown NCT NCT04607447
Low Intracranial Pressure Treatment Strategies for Chronic Subdural Hematoma Patients
Not yet reported Huashan Hospital 160 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: Chronic Subdural HematomaView official trial listing → -
Completed NCT NCT04626973
Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial
Not yet reported Yonsei University 3048 participants Est. completion 2025-09-24 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT04666389
The Role of Statins in the Prevention of Contrast-induced Acute Kidney Injury in Patients With Cardiovascular Diseases
Not yet reported I.M. Sechenov First Moscow State Medical University 150 participants Est. completion 2023-01-10 1 siteCardiovascular disease Other conditions: Contrast-induced Acute Kidney InjuryView official trial listing → -
Completed NCT NCT04721795
Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)
Not yet reported, Not yet reported Obafemi Awolowo University Teaching Hospital 150 participants Est. completion 2022-06-30 2 sites Stand-aloneOther conditions: Tuberculosis, Pulmonary, TuberculosisView official trial listing → -
Status unknown NCT NCT04754789
Effect of Upstream Treatment With High Intensity Statin on the Outcomes of STMI Patients Treated With PPCI
Not yet reported Assiut University 160 participants Est. completion 2021-03-01Cardiovascular diseaseView official trial listing → -
Terminated NCT NCT04764851
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Not yet reported Emalex Biosciences Inc. 30 participants Est. completion 2021-05-07 1 siteOther conditions: Drug-InteractionsView official trial listing → -
Active, not recruiting NCT NCT04767984
Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis
Not yet reported Northwestern University 42 participants Est. completion 2026-11-30 3 sites Stand-aloneOther conditions: Colorectal Carcinoma, Ulcerative ColitisView official trial listing → -
Status unknown NCT NCT04801940
HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID)
Not yet reported Cambridge University Hospitals NHS Foundation Trust 2631 participants Est. completion 2024-01-31 1 siteOther conditions: Covid19View official trial listing → -
Status unknown NCT NCT04813471
Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH
Not yet reported Lebanese American University Medical Center 70 participants Est. completion 2021-04-30 1 site Stand-aloneOther conditions: Covid19, Endothelial DysfunctionView official trial listing → -
Completed NCT NCT04824911
Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease
Not yet reported Chang Gung Memorial Hospital 376 participants Est. completion 2025-02-28 1 site Stand-aloneCardiovascular disease Other conditions: Dual Antiplatelet Therapy, StatinView official trial listing → -
Status unknown NCT NCT04900155
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
Not yet reported Penza State University 45 participants Est. completion 2024-12 1 siteOther conditions: STEMI, Covid19, NSTEMIView official trial listing → -
Active, not recruiting NCT NCT04904536
Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy
Not yet reported The George Institute 190 participants Est. completion 2025-07-30 1 site Stand-aloneOther conditions: Neurocognitive Impairment, MildView official trial listing → -
Status unknown NCT NCT04943783
Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms
Not yet reported Beijing Neurosurgical Institute 40 participants Est. completion 2022-07-30 2 sites Stand-aloneOther conditions: Dissecting Aneurysm of Cerebral Artery, Intramural Hematomas, Inflammation VascularView official trial listing → -
Status unknown NCT NCT04974814
Effect of Statin Preloading in STEMI in Improving PCI Outcomes
Not yet reported Beni-Suef University 99 participants Est. completion 2023-04 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT05072054
Comparison of Effects of Atorvastatin Versus Rosuvastatin on Cardiac Function in Heart Failure Patients
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 80 participants Est. completion 2022-08-31 1 site Stand-aloneHeart failureView official trial listing → -
Status unknown NCT NCT05165251
Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
Not yet reported Shanghai Jiao Tong University School of Medicine 480 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: Isolated Systolic HypertensionView official trial listing → -
Withdrawn NCT NCT05251129
Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation
Not yet reported Montefiore Medical Center Est. completion 2030-06 Stand-aloneOther conditions: VasculopathyView official trial listing → -
Completed NCT NCT05327595
A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)
Not yet reported Eli Lilly and Company 80 participants Est. completion 2024-04-22 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT05334108
Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport
Not yet reported Emalex Biosciences Inc. 56 participants Est. completion 2022-08-26 1 siteOther conditions: Drug InteractionView official trial listing → -
Completed NCT NCT05368545
Influence of Lipid Lowering on Impaired Coronary Flow
Not yet reported Aarhus University Hospital 109 participants Est. completion 2024-04-17 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT05395143
Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients
Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 92 participants Est. completion 2022-07-10 1 site Stand-aloneOther conditions: HyperlipidemiasView official trial listing → -
Completed NCT NCT05464628
Drug Interaction Study of ASC42 With Atorvastatin
Not yet reported Gannex Pharma Co., Ltd. 12 participants Est. completion 2022-08-30 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT05483894
Atorvastatin Use and Portal Hypertension in Patients With Hepatitis B Virus-related Liver Cirrhosis: A Randomized Controlled Trial
Not yet reported Samsung Medical Center 36 participants Est. completion 2025-01-31Other conditions: Hepatitis B, Portal HypertensionView official trial listing → -
Completed NCT NCT05488067
Atorvastatin Therapy on Xanthoma in Alagille Syndrome
Not yet reported Children's Hospital of Fudan University 15 participants Est. completion 2024-08-01 1 site Stand-aloneOther conditions: Alagille Syndrome, Atorvastatin, XanthomaView official trial listing → -
Status unknown NCT NCT05507398
The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer
Not yet reported Tanta University 100 participants Est. completion 2023-09Other conditions: Breast Cancer FemaleView official trial listing → -
Completed NCT NCT05551624
Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine
Not yet reported Hospital Civil de Guadalajara 15 participants Est. completion 2020-01-23 1 site Stand-aloneOther conditions: Primary Immune ThrombocytopeniaView official trial listing → -
Completed NCT NCT05555238
An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia
Hanmi Pharmaceutical Company Limited 1716 participants Est. completion 2022-01-27 1 siteOther conditions: DyslipidemiaView official trial listing → -
Completed NCT NCT05561062
Atorvastatin in Patients With Ulcerative Colitis
Not yet reported Tanta University 50 participants Est. completion 2024-11-01 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT05563389
Statin Impact on Hepatic Decompensation
Not yet reported, Not yet reported Tanta University 100 participants Est. completion 2023-02-25 1 siteOther conditions: Quality of Life, the Incidence of Whole Complications Resultant From Decompensated LiverView official trial listing → -
Completed NCT NCT05567068
Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
Not yet reported Tanta University 54 participants Est. completion 2025-06-01 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Status unknown NCT NCT05585151
High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200 participants Est. completion 2024-10-01 1 siteOther conditions: Cerebral AtherosclerosisView official trial listing → -
Not yet recruiting NCT NCT05589454
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
Not yet reported Sichuan Provincial People's Hospital 344 participants Est. completion 2027-06 5 sites Stand-aloneCardiovascular disease Other conditions: Cerebral MicrobleedsView official trial listing → -
Status unknown NCT NCT05697185
Safety and Efficacy of Evolocumab in Ischemic Stroke
Not yet reported Second Affiliated Hospital of Guangxi Medical University 200 participants Est. completion 2024-12-01 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05730634
The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 24 participants Est. completion 2022-05-06 1 site Stand-aloneType 2 diabetes Other conditions: Vascular InflammationView official trial listing → -
Status unknown NCT NCT05741086
Evolocumab Added to Statin Therapy in Symptomatic Intracranial Atherosclerotic Stenosis (EAST-ICAS)
Not yet reported The First Affiliated Hospital with Nanjing Medical University 80 participants Est. completion 2024-08-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05761444
Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
Not yet reported Organon and Co 137 participants Est. completion 2024-10-15 7 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05792540
Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
Not yet reported Tanta University 75 participants Est. completion 2024-12-20 1 siteOther conditions: Depressive DisorderView official trial listing → -
Completed NCT NCT05806723
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men
Not yet reported Hopital La Rabta 104 participants Est. completion 2022-09-15 1 site Stand-aloneType 2 diabetes Other conditions: Dyslipidemia Associated With Type II Diabetes Mellitus, Statin Adverse Reaction, Hypogonadism, Male, Adrenal Insufficiency, Vitamin D DeficiencyView official trial listing → -
Status unknown NCT NCT05812404
Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects
Not yet reported Daewoong Pharmaceutical Co. LTD. 36 participants Est. completion 2023-06-16 1 site Stand-aloneOther conditions: Drug Drug InteractionView official trial listing → -
Enrolling by invitation NCT NCT05870007
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Not yet reported Taipei Medical University Shuang Ho Hospital 30 participants Est. completion 2026-12 3 sitesChronic kidney disease Other conditions: Autosomal Dominant Polycystic Kidney DiseaseView official trial listing → -
Completed NCT NCT05877235
Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:
Not yet reported InCor Heart Institute 60 participants Est. completion 2024-06-23 1 site Stand-aloneCardiovascular disease Other conditions: MenopauseView official trial listing → -
Status unknown NCT NCT05893849
Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults
Peking University Third Hospital 624 participants Est. completion 2024-04 1 siteOther conditions: AgingView official trial listing → -
Completed NCT NCT05895123
Comparison Between the Effects of High Doses Statin on Ventricular Remodeling in STEMI Patients
Not yet reported Damanhour University 80 participants Est. completion 2023-04-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT05930028
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
Not yet reported Boryung Pharmaceutical Co., Ltd 148 participants Est. completion 2024-09-05 1 site Stand-aloneOther conditions: Essential Hypertension, Primary HypercholesterolemiaView official trial listing → -
Status unknown NCT NCT05933720
Efficacy and Safety of the Regulatory Polypeptides in Patients With Peripheral Atherosclerosis.
Not yet reported Ryazan State Medical University 120 participants Est. completion 2026-09-01 1 siteOther conditions: Peripheral Arterial Occlusive DiseaseView official trial listing → -
Status unknown NCT NCT05976893
Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer
Not yet reported Xiang Xie 620 participants Est. completion 2025-12-31 Stand-aloneCardiovascular disease Other conditions: Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor, CancerView official trial listing → -
Completed NCT NCT06024096
Systems Biological Assessment of Statin Effect on Vaccine Responses
Not yet reported Emory University 63 participants Est. completion 2024-12-16 1 siteOther conditions: Vaccine ResponseView official trial listing → -
Completed NCT NCT06081166
A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
Not yet reported NewAmsterdam Pharma 74 participants Est. completion 2024-01-22 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT06083337
Vascular Inflammation ReDuction and Perivascular Fat Imaging by Computed Tomography
Not yet reported Hippocration General Hospital 140 participants Est. completion 2025-07-22 1 site Stand-aloneCardiovascular disease Other conditions: Atheroscleroses, Coronary, Vascular InflammationView official trial listing → -
Status unknown NCT NCT06134635
Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke
Xuanwu Hospital, Beijing 80 participants Est. completion 2024-12-01Cardiovascular diseaseView official trial listing → -
Completed NCT NCT06139952
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
Not yet reported Ain Shams University 120 participants Est. completion 2024-07-01 1 site Stand-aloneCardiovascular disease Other conditions: Nephropathy; Toxic, DrugsView official trial listing → -
Completed NCT NCT06191991
A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Not yet reported Aligos Therapeutics 14 participants Est. completion 2023-12-04 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT06273215
Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients
Not yet reported Peking University Third Hospital 48 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Withdrawn NCT NCT06280976
Aggressive Risk-Prevention Therapies for Coronary Atherosclerotic Plaque (ART-CAP)
Not yet reported University of Louisville Est. completion 2025-01-01 1 site Stand-aloneCardiovascular disease Other conditions: Atherosclerosis, Heart AttackView official trial listing → -
Status unknown NCT NCT06286059
Efficacy of Phentolamine in Prevention of Contrast-Associated Acute Kidney Injury After Complex PCI
Not yet reported, Not yet reported Helwan University 60 participants Est. completion 2025-01-31 1 siteCardiovascular disease Other conditions: CA-AKI - Contrast-Associated Acute Kidney Injury, Acute Coronary Syndrome, Adrenergic Receptor Antagonist Adverse ReactionView official trial listing → -
Enrolling by invitation NCT NCT06369571
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Not yet reported, Not yet reported Johns Hopkins University 22 participants Est. completion 2027-12 1 siteOther conditions: Epilepsy, DyslipidemiaView official trial listing → -
Active, not recruiting NCT NCT06372925
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction
Not yet reported Novartis Pharmaceuticals 318 participants Est. completion 2027-01-26 19 sites Stand-aloneOther conditions: Plaque, AtheroscleroticView official trial listing → -
Status unknown NCT NCT06382974
Evaluation of the Osteoinductivity of Atorvastatin Combined With β-TCP
Not yet reported Cairo University 10 participants Est. completion 2026-03 1 site Stand-aloneOther conditions: Infection, Bone LossView official trial listing → -
Completed NCT NCT06403787
Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment
Not yet reported, Not yet reported University of Guadalajara 28 participants Est. completion 2024-04-01 1 siteOther conditions: Human Immunodeficiency VirusView official trial listing → -
Completed NCT NCT06545461
Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes
Not yet reported Donald Wesson 108 participants Est. completion 2016-10-30 Stand-aloneChronic kidney diseaseCardiovascular disease Other conditions: HypertensionView official trial listing → -
Not yet recruiting NCT NCT06559072
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
Not yet reported The George Institute 522 participants Est. completion 2026-09-01 1 site Stand-aloneOther conditions: Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal, Aneurysmal Subarachnoid Hemorrhage, Hemorrhage, Aneurysmal SubarachnoidView official trial listing → -
Completed NCT NCT06615284
A Study of Atorvo+™ in Healthy Adult Participants
Not yet reported Indication Bioscience LLC 24 participants Est. completion 2025-06-10 1 site Stand-aloneOther conditions: Coronary Heart Disease, DyslipidemiasView official trial listing → -
Completed NCT NCT06642740
Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia
Beijing Ditan Hospital 108 participants Est. completion 2025-06-01 1 siteOther conditions: Chronic Liver Disease, ThrombopeniaView official trial listing → -
Completed NCT NCT06674044
Effect of SLC01B1 (rs2306283) Polymorphism on the Efficacy and Safety Profile of Atorvastatin in Pakistani Population
Riphah International University 100 participants Est. completion 2024-08-31 1 siteOther conditions: HyperlipidemiasView official trial listing → -
Not yet recruiting NCT NCT06684509
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Not yet reported, Not yet reported Assiut University 46 participants Est. completion 2029-09 1 siteOther conditions: Leukemia, Hodgkin DiseaseView official trial listing → -
Completed NCT NCT06782243
Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome
Not yet reported Khyber Medical University Peshawar 190 participants Est. completion 2025-08-25 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Not yet recruiting NCT NCT06791031
PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)
Not yet reported West China Hospital 212 participants Est. completion 2028-06 Stand-aloneCardiovascular diseaseView official trial listing → -
Not yet recruiting NCT NCT06856772
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
Not yet reported Tor Biering-Sørensen 42000 participants Est. completion 2028-03-28 1 site Stand-aloneCardiovascular disease Other conditions: Drug EffectView official trial listing → -
Completed NCT NCT06871358
The Effect of Atorvastatin 80 mg on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in PCI-STEMI Patients
Not yet reported Universitas Sebelas Maret 40 participants Est. completion 2024-11-20 1 siteOther conditions: STEMI (STE-ACS), Primary PCI for STEMIView official trial listing → -
Completed NCT NCT06948747
A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants
Not yet reported AstraZeneca 49 participants Est. completion 2025-10-03 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Active, not recruiting NCT NCT06976866
Effect of Topical Application of Atorvastatin Gel Versus Hyaluronic Acid on Immediate Loading Dental Implant in Posterior Maxilla
Not yet reported Amira attia 21 participants Est. completion 2025-05-14 1 site Stand-aloneOther conditions: In Recent Years, There Has Been a Rise in the Use of Immediate Loading Protocols, Dental Implant StabilityView official trial listing → -
Not yet recruiting NCT NCT07087379
Perioperative Intensive Statin Therapy for Neuroprotection in TAVR（PISTNT）
Not yet reported Pan Xiangbin 500 participants Est. completion 2028-01-01 Stand-aloneOther conditions: Aortic Stenosis, Cerebral Ischaemic InjuryView official trial listing → -
Completed NCT NCT07128212
Atorvastatin Mitigates WMH-Related Cognitive Impairment by Reducing VCAM-1
Not yet reported Suzhou Municipal Hospital of Anhui Province 401 participants Est. completion 2022-12-31 1 site Stand-aloneOther conditions: Ischemic White Matter Lesions (WMIL), Cerebral Small Vessel Disease, Vascular Cell Adhesion Molecule-1, VCAM-1View official trial listing → -
Not yet recruiting NCT NCT07197463
The Therapeutic Effect of Phase I Cardiac Rehabilitation on Elderly Patients With CHD Complicated by Sarcopenia
Not yet reported Qilu Hospital of Shandong University 100 participants Est. completion 2026-11-10 Stand-aloneOther conditions: Coronary Disease, SarcopeniaView official trial listing → -
Not yet recruiting NCT NCT07290699
Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period
Not yet reported Second Affiliated Hospital of Nanchang University 2442 participants Est. completion 2028-08-30 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT07301372
Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke
Not yet reported The Affiliated Hospital of Xuzhou Medical University 132 participants Est. completion 2026-06-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Not yet recruiting NCT NCT07462715
Statins Against Bushfire Smoke
Not yet reported Menzies Institute for Medical Research 100 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Healthy AdultsView official trial listing → -
Not yet recruiting NCT NCT07474649
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
Not yet reported Daiichi Sankyo 103 participants Est. completion 2028-10-02 12 sites Stand-aloneOther conditions: Coronary Atherosclerosis, Mixed Dyslipidemia, HypercholesterolemiaView official trial listing → -
Not yet recruiting NCT NCT07508254
Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome
Not yet reported Punjab Institute of Cardology 120 participants Est. completion 2026-10-31 1 site Stand-aloneOther conditions: Acute Coronary Syndromes (ACS), HypercholesterolemiaView official trial listing → -
Enrolling by invitation NCT NCT07568574
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Not yet reported Enhanced Emirates Limited 60 participants Est. completion 2033-03-01 1 site Stand-aloneOther conditions: Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite AthletesView official trial listing → -
Not yet recruiting NCT NCT07605130
Efficacy and Safety Study of Digital Cognitive Training and PCSK9 Inhibitor-Enhanced Lipid-lowering Strategy in Patients With Intracranial Atherosclerotic Stenosis: A 2x2 Factorial, Randomized, Parallel-Group, Multicenter Trial
Not yet reported Peking Union Medical College Hospital 440 participants Est. completion 2029-07-31 1 site Stand-aloneOther conditions: Intracranial Arteriosclerosis, Cognitive ImpairmentView official trial listing → -
Not yet recruiting NCT NCT07626840
Livalozet Versus High-intensity Statin in Older Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Not yet reported Samsung Medical Center 5000 participants Est. completion 2031-12-31Other conditions: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)View official trial listing → -
Not yet recruiting NCT NCT07630363
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
Not yet reported, Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40 participants Est. completion 2030-04-01 1 site Stand-aloneOther conditions: Advanced Renal Cell Carcinoma (RCC), PTC, Atorvastatin, Targeted Therapy Combined With ImmunotherapyView official trial listing → -
Not yet recruiting NCT NCT07634341
Clinical and Radiographic Evaluation of Doxycycline and Atorvastatin Loaded Chitosan Nanoparticles as an Adjunctive to Scaling and Root Planning in the Management of Chronic Periodontitis. A Randomized Controlled Clinical Trial.
Not yet reported Fayoum University 80 participants Est. completion 2027-12 1 siteOther conditions: Chronic PeriodontitisView official trial listing → -
Completed NCT NCT07668076
The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients
Not yet reported Damanhour University 44 participants Est. completion 2024-10-20 1 site Stand-aloneOther conditions: Breast Cancer, Doxorubicin Induced CardiomyopathyView official trial listing → -
Not yet recruiting NCT NCT07699003
Endovascular Treatment of Chronic Intracranial Artery Occlusion
Not yet reported Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 382 participants Est. completion 2030-08-01Other conditions: Chronic Intracranial Artery OcclusionView official trial listing → -
Completed NCT NCT07717788
Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients
Not yet reported Alkufa university\\collage of pharmacy 65 participants Est. completion 2026-07-01 1 site Stand-aloneOther conditions: Osteoporosis, Postmenopausal, Statin TherapyView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Atorvastatin Calcium Trihydrate, Atorvastatin calcium, Amlodipine and Atorvastatin, Atorvastatin
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.